US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

39.10

+0.24000.62%

Post-market: 38.75-0.3500-0.90%19:55 EDT

Volume:185.81K

Turnover:7.20M

Market Cap:211.33M

PE:- -

High:39.53

Open:39.11

Low:37.67

Close:38.86

52wk High:42.63

52wk Low:13.60

Shares:5.40M

Float Shares:5.40M

Volume Ratio:0.58

T/O Rate:3.44%

Dividend:17.77

Dividend Rate:45.44%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

Moderna President Stephen Hoge Disposes of 80,575 Common Shares Worth $11.78 Million

Cboe data shows mixed options sentiment in Moderna with shares down 2.14%

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Barclays downgrades Scholar Rock on valuation after FDA approval

Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Scholar Rock price target raised to $84 from $76 at BMO Capital

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Scholar Rock announces FDA approval of isembyld

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Pharming wins FDA nod to extend Joenja use to younger APDS children

Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis

Moderately bullish activity in Moderna with shares up 8.03%

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating

MT Newswires Live

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

Walvax Biotechnology's Subsidiary Secures Regulatory Approval for COVID-19 mRNA Vaccine

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/MRNY/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MRNY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNY\",,,,,undefined,":{"symbol":"MRNY","market":"US","secType":"STK","nameCN":"YieldMax MRNA Option Income Strategy ETF","latestPrice":39.1,"timestamp":1790971200000,"preClose":38.86,"halted":0,"volume":185806,"hourTrading":{"tag":"盘后","latestPrice":38.75,"preClose":39.1,"latestTime":"19:55 EDT","volume":4353,"amount":169842.0314,"timestamp":1790985314620,"change":-0.35,"changeRate":-0.008951,"amplitude":0.008951},"delay":0,"changeRate":0.006176016469377303,"floatShares":5404973,"shares":5404973,"eps":0,"marketStatus":"Market Closed","change":0.24,"latestTime":"10-02 16:00:00 EDT","open":39.11,"high":39.53,"low":37.67,"amount":7204086.397121999,"amplitude":0.047864,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":38.86,"sharesOutstanding":6479974,"nav":38.68,"aum":209064394.32,"dividendRate":0.45439,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.1,"preClose":38.86,"latestTime":"09:27 EDT","volume":4085,"amount":160609.61820000003,"timestamp":1790947663636,"change":0.24,"changeRate":0.006176,"amplitude":0.017499},"postHourTrading":{"tag":"盘后","latestPrice":38.75,"preClose":39.1,"latestTime":"19:55 EDT","volume":4353,"amount":169842.0314,"timestamp":1790985314620,"change":-0.35,"changeRate":-0.008951,"amplitude":0.008951},"volumeRatio":0.5762908023496166,"impliedVol":0.6931,"impliedVolPercentile":0.868},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNY\",,,,,undefined,":{"symbol":"MRNY","floatShares":5404973,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5762908023496166,"shares":5404973,"dividePrice":17.766667,"high":39.53,"amplitude":0.047864,"preClose":38.86,"low":37.67,"week52Low":13.6,"pbRate":"--","week52High":42.6326,"institutionHeld":0,"latestPrice":39.1,"eps":0,"divideRate":0.45439,"volume":185806,"delay":0,"ttmEps":0,"open":39.11,"prevYearClose":14.7,"prevWeekClose":40.77,"prevMonthClose":40.21,"prevQuarterClose":40.21,"fiveDayClose":40.77,"twentyDayClose":33.9,"sixtyDayClose":19.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNY\",params:#limit:5,,,undefined,":[{"date":"2026-10-01","symbol":"MRNY","amount":0.8073,"announcedDate":"2026-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-10-01","defaultRemindTime":1790861400000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-10-01","currency":"USD","dateTimestamp":1790827200000,"payDate":"2026-10-02"},{"date":"2026-09-24","symbol":"MRNY","amount":0.6367,"announcedDate":"2026-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-24","defaultRemindTime":1790256600000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-24","currency":"USD","dateTimestamp":1790222400000,"payDate":"2026-09-25"},{"date":"2026-09-17","symbol":"MRNY","amount":0.5672,"announcedDate":"2026-09-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-17","defaultRemindTime":1789651800000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-17","currency":"USD","dateTimestamp":1789617600000,"payDate":"2026-09-18"},{"date":"2026-09-10","symbol":"MRNY","amount":0.642,"announcedDate":"2026-09-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-10","defaultRemindTime":1789047000000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-11","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1789012800000,"payDate":"2026-09-11"},{"date":"2026-09-03","symbol":"MRNY","amount":0.6373,"announcedDate":"2026-09-02","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-03","defaultRemindTime":1788442200000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-04","payableDate":"2026-09-03","currency":"USD","dateTimestamp":1788408000000,"payDate":"2026-09-04"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNY\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-07","recordDate":"2023-12-08","paymentDate":"2023-12-13","value":0.413,"currency":"USD"},{"executeDate":"2024-01-05","recordDate":"2024-01-08","paymentDate":"2024-01-09","value":2.6542,"currency":"USD"},{"executeDate":"2024-02-07","recordDate":"2024-02-08","paymentDate":"2024-02-09","value":0.5944,"currency":"USD"},{"executeDate":"2024-03-06","recordDate":"2024-03-07","paymentDate":"2024-03-08","value":1.131,"currency":"USD"},{"executeDate":"2024-04-04","recordDate":"2024-04-05","paymentDate":"2024-04-08","value":0.7832,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNY\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668963474","title":"Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963474","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963474?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637420,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that theFDA approved Kerendia to reduce urinary albumin-to-creatinine ratio, which is expected to reduce the risk of sustai...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVIB","GNMX","MRNX","MEDI","IDNA","PINK","BK4588","SYNB","GDOC","BBP","LABU","PSCH","BMED","FRTY","TBXU","TECB","MRNY","IYH","XLVX","BAYRY","LFSC","IEIH","IBB","RSPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668109935","title":"Moderna President Stephen Hoge Disposes of 80,575 Common Shares Worth $11.78 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2668109935","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668109935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:49","pubTimestamp":1789591761,"startTime":"0","endTime":"0","summary":"Moderna President Stephen Hoge disposes of 80,575 common shares worth $11.78 millionModerna President Stephen Hoge cut his direct common-stock stake to 1,562,029 shares via option exercises, then sale","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL32Fyc6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","IDNA","BK4533","WDNA","BK4548","LGHT","BK4532","MRNX","MRNY","BK4585","BK4534","BK4551","BK4139","BK4501","BK4568","GNOM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667214586","title":"Cboe data shows mixed options sentiment in Moderna with shares down 2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667214586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667214586?lang=en_us&edition=fundamental","pubTime":"2026-09-16 02:50","pubTimestamp":1789498212,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Moderna (MRNA), with shares down $3.15 near $143.54. Options volume relatively light with 39k contracts ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-down-2-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-down-2-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","GNOM","BK4551","MRNX","BK4532","BK4568","MRNY","BK4548","MRNA","LGHT","BK4139","BK4588","IDNA","BK4501","BK4533","BK4585","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["IDNA","NVIB","PSCH","TECB","MEDI","BK4585","BMED","XBIX","IEIH","IYH","MRNX","MRNY","SYNB","GNMX","IBB","BBP","LABU","RSPH","BK4588","GDOC","TBXU","FRTY","PINK","LFSC","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","XLVX","TACU","NVIB","BMED","LFSC","IYH","LABU","FRTY","BBP","TSPA","MEDI","IEIH","TECB","GNMX","CDIG","PINK","MRNY","IBB","SYNB","GDOC","IDNA","RSPH","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695518","title":"Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695518","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695518?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:25","pubTimestamp":1789417559,"startTime":"0","endTime":"0","summary":"Moderna CFO James M. Mock disposes of 34,836 common shares worth $4.68 millionModerna CFO Mock James M disclosed sales of 34,836 common shares on Sep. 10, 2026 at USD 134.49.He also exercised stock op","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL8rXTDg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","MRNA","BK4551","WDNA","MRNY","BK4548","GNOM","MRNX","IDNA","BK4139","BK4501","BK4588","LGHT","BK4568","BK4533","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GDOC","FRTY","BK4585","BFRI","XLVX","LFSC","BMED","MRNY","LABU","TBXU","TECB","SYNB","BK4588","NVIB","PINK","PSCH","BBP","IYH","GNMX","MEDI","IBB","IEIH","MRNX","RSPH","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","GDOC","PSCH","SYNB","PINK","MRNY","NVIB","BMED","LABU","LFSC","IEIH","TBXU","IBB","IYH","IDNA","BK4588","GNMX","MRNX","BK4585","RSPH","FRTY","MEDI","TECB","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECB","XLVX","MRNX","PINK","TBXU","SYNB","GNMX","GDOC","THNR","PSCH","BBP","MEDI","LABU","IDNA","BMED","BK4585","BK4588","MRNY","BK4139","IBRN","SRRK","FRTY","LFSC","IBB","IYH","NVIB","RSPH","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4179","MRNY","TECB","FRTY","MRNX","IBB","MEDI","BK4139","IDNA","NVIB","TBXU","PINK","BMED","FET","GNMX","GDOC","SYNB","BBP","BK4588","LABU","TLX","LFSC","IYH","RSPH","BK4585","PSCH","IEIH","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IBRN","IBB","LABU","IDNA","RSPH","TECB","SRRK","IYH","MRNY","BK4585","NVIB","BMED","FRTY","BBP","XLVX","TBXU","THNR","MRNX","BK4588","PINK","LFSC","PSCH","SYNB","MEDI","GNMX","IEIH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574302","title":"Moderna Inc. Stock Rallies 5.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574302?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 5.4% to $143.97 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 26,333.04 and the Dow Jones Industrial Average rising 1.0% to 52,573.29.This was the stock's second consecutive day of gains.Moderna Inc. closed 18.5% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.3% to $265.58, Pfizer Inc. rose 0.3% to $27.72, and Gilead Sciences Inc. fell 0.75% to $143.72.Trading volume totaled 15.3 million, compared to the 50-day average of 17.4 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBBQ","LU0965509283.SGD","IBB","BK4534","IDNA","LGHT","LU1430594728.SGD","BIB","BK4548","GNOM","LU1066051498.USD","LU1585245621.USD","LU0965509101.SGD","BBH","LU0889565916.HKD","LU1674673691.USD","MRNA","LU2468319806.SGD","IE00BKVL7J92.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU0965508806.USD","LU0289739699.SGD","LU1778281490.HKD","LU1934455277.USD","SG9999015952.SGD","SG9999015986.USD","MRNY","LU0058720904.USD","IE00B19Z3581.USD","BK4568","LU0114720955.EUR","LU0965509010.AUD","BMED","GILD","LU2357627491.SGD","SG9999015978.USD","BK4578","TBXU","LU1674673428.USD","BK4588","MRNX","LU0861579265.USD","LU1057294990.SGD","LU0109394709.USD","TMED","LU1571399168.USD","MEDI","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","MRNX","GDOC","IYH","FRTY","IEIH","LFSC","TECB","MEDI","NVIB","TBXU","LABU","SYNB","RSPH","IDNA","GNMX","PINK","PSCH","MRNY","BMED","BK4588","BBP","XLVX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666575576","title":"Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2666575576","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666575576?lang=en_us&edition=fundamental","pubTime":"2026-09-12 01:15","pubTimestamp":1789146928,"startTime":"0","endTime":"0","summary":"• Moderna experienced upward volatility driven by renewed institutional buying and consolidation.\n• Phase 3 trial results for intismeran autogene validated its oncology platform.\n• Latest annual revenue is $1.94B with a net loss of $-2.82B.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262164027-market-movers-mrna-20260911","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BK4588","MRNY","BK4568","BK4532","BK4533","BK4534","BK4585","BK4551","LGHT","BK4501","BK4139","BK4548","MRNA","GNOM","IDNA","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666576334","title":"Moderately bullish activity in Moderna with shares up 8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666576334","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666576334?lang=en_us&edition=fundamental","pubTime":"2026-09-12 01:00","pubTimestamp":1789146015,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Moderna (MRNA), with shares up $10.97, or 8.03%, near $147.59. Options volume roughly in line with average with 139k...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-8-03-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-8-03-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4534","BK4551","BK4501","IDNA","LGHT","MRNY","BK4585","GNOM","MRNA","MRNX","WDNA","BK4548","BK4588","BK4568","BK4532","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666573009","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2666573009","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666573009?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:00","pubTimestamp":1789142409,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeDell Technologies IncDELL.N+11.0%Hewlett Packard Enterprise CompanyHPE.N+9.1%Skyworks Solutions, Inc.SWKS.OQ+8.1%Moderna, Inc.MRNA.OQ+8.1%Flex LtdFLEX.OQ+7.8%Bottom PerformersPercent ChangeSeagate Technology Holdings PLCSTX.OQ-3.6%Baker Hughes CompanyBKR.OQ-3.1%SanDisk CorporationSNDK.OQ-3.1%The Clorox CompanyCLX.N-2.9%Palo Alto Networks, Inc.PANW.OQ-2.6%As of 12:00 p.m., the S&P 500.SPXgained 78.63 points, or 1.04%, to 7,670.33 and had posted 7 new 52-week highs and 6 new lows.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL8N4531EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z8X17.USD","SCHM","XYLD","RULE","SPXU","BK4018","HIBL","LU0234570918.USD","SPYU","BK4170","BK4581","LU2106854487.HKD","LU2065169927.USD","SMAX","LU1571399168.USD","ACWI","LU2272731782.SGD","LU1670627923.USD","LU1046421795.USD","IE00B19Z3581.USD","STX","MRNX","LU0225284248.USD","SPHD","LU1989764664.SGD","FXL","LU1303367103.USD","SNDG","LU2063271972.USD","LU2360107168.USD","LU2543165471.USD","LU0496365809.HKD","LU1992135399.USD","BK4550","STXL","SCHX","LU2355687059.USD","SFY","IE00B19Z3B42.SGD","IHAK","LU2265009873.SGD","LU0128525689.USD","LU0306806265.USD","WLDR","LU1923622291.USD","FSMD","SPUS","SPYH","LU2290526834.HKD","LU2023250843.SGD","BUG","BK4598",".SPX","SPYV","LU1153585028.USD","LU0823421333.USD","BK4179","LU0719512351.SGD","LU2210149790.SGD","LU1712237335.SGD","LU1169589451.USD","VOO","IE00B894F039.SGD","LU0081259029.USD","LU0289960550.SGD","LU2463526074.USD","BK4548","BK4554","LU0511384066.AUD","PANG","PTF","SNXX","UPRO","XDTE","COWG","YSPY","IVW","SPYQ","IE00BKVL7J92.USD","BK4532","LU0321505439.SGD","LU0345770308.USD","LU0345770993.USD","LU0011850046.USD","LU1983260115.SGD","LU1670628061.USD","MOAT","AIFD","SH","LU0175139822.USD","LU1084165304.USD","LU1548497426.USD","LU2065171402.SGD","BK4568","LU0203345920.USD","IEZ","BK4560","VTI","SPMO","LU0823434740.USD","IE00B19Z9505.USD","VOOG","XLG","LU0187121727.USD","FLEX","GSLC","LU0124676726.USD","MRNY","LU0310800965.SGD","LU0211326839.USD","BKR","STXU","DELL","RSPN","LU1861215975.USD","PALD","LU2023250504.SGD","LU2125909759.SGD","ETFT","VEU","LU0267386448.USD","IJH","DLLL","LU0823434583.USD","IE00BMPRXR70.SGD","IE00BN0W2W23.USD","LU0154245673.USD","LU0203347892.USD","IGV","LU1235294995.USD","LU1720051108.HKD","BK4533","LU2065170008.USD","LU0006061336.USD","PSWD","SNDK","SPXS","OIH","ITOT","LU0348723411.USD","QQQA","SCHA","BK4588","CNAV","LU0057025933.USD","BK4097","IE00BZ1G4Q59.USD","LU2244417387.USD","WDNA","CLOD","LU0082616367.USD","IE00B19Z8W00.USD","HAKY","LU1861220033.SGD","NOBL","LU0472753341.HKD","PALU","SDS","LU1267930227.SGD","BK4145","SNDC","OPTZ","SPLV","LU1366192091.USD","LU0070302665.USD","LU0289739343.SGD","LU2473716301.USD","HPE","SWKS","BK4504","LU2065171311.SGD","SPY","BK4141","LGHT","LU2095319765.USD","LU2286300806.USD","LU1992135472.HKD","VBK","LU0823421416.USD","LU1989764748.USD","LU0052756011.USD","LU0251142724.SGD","LU0976567544.SGD","FLEL","IE00B19Z9Z06.USD","LU1169590202.USD","LU1623119135.USD","LU0211326755.USD","PXJ","LU0054578231.USD","DMAX","SPHQ","FCUS","CLX","IE00B7SZLL34.SGD","IVV","SNDU","QQQG","LU0069063385.USD","LU0320765489.SGD","BK4534","EGGY","BMAY","BK4139","SCHB","WCBR","BK4512","BK4535","RSP","LU0266013472.USD","GNOM","LU0963586101.USD","LU1823568750.SGD","CIBR","BK4566","IE00BMPRXN33.USD","LU2322448791.USD","IVE","LU1917777945.USD","LU1261432733.SGD","LU0225771236.USD","LU1974910355.USD","LU2098885051.SGD","IE00BN0W2T93.GBP","LU2272731600.USD","TMSL","LU2125909916.SGD","RSPU","MRNA","DBSC","SPGP","BK4515","VTV","LU0306807586.USD","LU2272731865.HKD","BK4567","LU0321505868.SGD","LU1119994496.HKD","SPUU","SPAM","BK4501","BK4605","BK4585","DISK","PANW","MMAX","LU0689626769.HKD","BK4543","SSO","TSPY","LU0048573561.USD","LU2357305700.SGD","SPYG","LU0256331488.USD","SG9999001424.SGD","SNDQ","LU0154245756.USD","LU0211331839.USD","BK4551","GPIX","IDNA","LU1804176565.USD","RSPA","LU2210150020.SGD","SPYD","IJR","IE00BN0W2V16.EUR","SPDN","LU0251131958.USD","LU1720051017.SGD","LU0985481810.HKD","HIBS","SPXL","STXX","LU0208291251.USD","ALLW","DRMY","LU0742534661.SGD","LU2322448957.HKD","VV","IE0002270589.USD","JEPI","WCLD","SPYM","IE00B19Z9P08.USD","HPEL","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529289","title":"Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529289","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666529289?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:22","pubTimestamp":1789125772,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $112.72, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4139","BK4501","IDNA","MRNY","BK4548","BK4532","BK4551","GNOM","LGHT","BK4568","BK4534","BK4533","MRNA","BK4585","WDNA","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666422435","title":"Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666422435","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666422435?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:20","pubTimestamp":1789114812,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Moderna (MRNA), Merck & Company (MRK) and Pacific ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-moderna-mrna-merck-company-mrk-and-pacific-biosciences-pacb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-moderna-mrna-merck-company-mrk-and-pacific-biosciences-pacb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","LU0868494708.USD","BK4533","PPH","BK4007","RXL","LU2023250504.SGD","LU2468319806.SGD","SG9999015358.SGD","IE00B1BXHZ80.USD","MRNX","LU1032466523.USD","LU1066053197.SGD","LU1116320737.USD","WDNA","LU0124676726.USD","LU1066051811.HKD","LU2491049909.HKD","LU0320765646.SGD","TRUH","BK4551","LU0203347892.USD","LU0238689110.USD","IE00BJT1NW94.SGD","LU0432979614.USD","LU1929549753.HKD","LU2361044949.HKD","LU1934455194.USD","LU0106261372.USD","LU2125909593.SGD","BK4585","IE0009355771.USD","IE00BLSP4452.SGD","LU1430594728.SGD","LU2125909247.SGD","IE00BN8TJ469.HKD","LU1989771016.USD","BK4550","LU1023059063.AUD","LU1061106388.HKD","LU2433249047.HKD","SG9999013999.USD","LU0130517989.USD","LU2491050154.USD","LU0965508806.USD","LU1585245621.USD","LU1941712264.USD","LU0965509010.AUD","LU0234572021.USD","LU0203345920.USD","LU0058720904.USD","LU0122379950.USD","LU1035773651.USD","LU0689626769.HKD","LU0208291251.USD","BK4534","MRNA","SG9999002224.SGD","LU0320765489.SGD","SG9999014559.SGD","SG9999014575.USD","LU2112291526.USD","LU0289739699.SGD","IDNA","GNOM","LU1162221912.USD","IXJ","VHT","LU0823416689.USD","LU1093756168.USD","BK4121","LU2357627491.SGD","LU0965509101.SGD","LGHT","IE00BJJMRZ35.SGD","IE00BLSP4239.USD","LU0648001328.SGD","SG9999014542.SGD","PAWZ","LU1934455277.USD","BK4532","BK4568","LU1989772923.USD","GDOC","BMED","LU0985320562.USD","MRK","LU0070302665.USD","LU2360032135.SGD","MRNY","LU1069347547.HKD","LU0861579265.USD","LU2106854487.HKD","SG9999015341.SGD","LU1974910355.USD","IYH","BK4588","BK4501","LU1923622614.USD","LU1037948541.HKD","LU0211331839.USD","SG9999002232.USD","LU1934455863.HKD","LU1201861249.SGD","LU2361044865.SGD","SG9999001176.USD","SG9999001440.SGD","LU2324357040.USD","LU0006306889.USD","LU0265550359.USD","LU0868494617.USD","IHE","LU0980610538.SGD","LU1291159041.SGD","LU0942090050.USD","IE00BBT3K403.USD","LU2023250843.SGD","LU1699723380.USD","LU1989772840.SGD","IE00B4R5TH58.HKD","LU1093756325.SGD","HRTS","BK4548","IE00B2B36J28.USD","LU1571399168.USD","LU1066051225.USD","LU0965509283.SGD","IE000M9KFDE8.USD","LU2089984988.USD","LU0098860793.USD","IE00BFTCPJ56.SGD","LU1941712348.USD","LU1983299246.USD","LU1066051498.USD","IE00BSNM7G36.USD","LU2461242641.AUD","BK4139","SGXZ57979304.SGD","IE0002141913.USD","BK4559","LU1116320901.HKD","PACB","LU0266013472.USD","LU0477156953.USD","LU1917777945.USD","SG9999001176.SGD","LU1037948897.HKD","FHLC","LU2125154778.USD","LU2361045086.USD","JDOC","LU2125154935.USD","LU0130102774.USD","LU0859254822.USD","BK4516","LU2491050071.SGD","SG9999014567.USD","FTXH","LU0265550946.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158588840","title":"Walvax Biotechnology's Subsidiary Secures Regulatory Approval for COVID-19 mRNA Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1158588840","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158588840?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:08","pubTimestamp":1789045687,"startTime":"0","endTime":"0","summary":"Walvax Biotechnology Co.,Ltd. (300142.SZ) has officially announced that its wholly-owned subsidiary, Yuxi Walvax Biotechnology Co., Ltd., received the \"COVID-19 mRNA Vaccine\" Drug Registration...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0070","BK0046","MRNX","BK0239","300142","BK0077","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666311265","title":"Moderna Set for 3 Near-Term INT Data Readouts, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666311265","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666311265?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:58","pubTimestamp":1788969505,"startTime":"0","endTime":"0","summary":"Moderna  is set for three data readouts on its individualized neoantigen therapies, or INT, in the near term, serving as potential stock catalysts for the company, UBS Securities said in a Tuesday note.The next major catalyst is the release of phase 3 data on melanoma at an international conference this fall, investors awaiting efficacy on recurrence-free survival and distant metastasis-free survival, the brokerage said.Likely to follow is the phase 2 data on either renal cell carcinoma or muscle-invasive bladder cancer, potentially in 2027, according to UBS. The next readout is probably a phase 3 update on adjuvant non-small cell lung cancer, the investment firm added.UBS has a neutral rating and $150 price target on Moderna.Price: 137.50, Change: -2.83, Percent Change: -2.02","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LGHT","BK4533","GNOM","BK4551","IDNA","MRNX","BK4501","BK4568","BK4139","MRNA","BK4585","BK4588","BK4534","BK4548","WDNA","BK4532","MRNY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}